August 6, 2009 - The use of digital breast tomosynthesis and full-field digital mammography (FFDM) combined may be associated with a substantial decrease in recall rate, according to a study performed at UPMC in Pittsburgh, Penn., published in the American Roentgen Ray Society.

An estimated 10 percent of women in the United States are recalled for a second mammogram after an abnormality is detected on the first one. Some researchers believe that digital breast tomosynthesis depicts the breast tissue in a way which may allow radiologists to identify some tumors which could be missed with standard two-dimensional mammography.

In the study, 125 patients were evaluated using a combined method of digital breast tomosynthesis and standard digital mammography. The use of digital breast tomosynthesis and FFDM was associated with a 30 percent reduction in recall rate for cancer-free examinations that would have led to recall if FFDM had been used alone, reported Jules H. Sumkin, M.D., one of the authors of the study.

Source: American Roentgen Ray Society.

For more information: http://www.ajronline.org


Related Content

News | RSNA

November 30, 2023 — Breast cancer mortality is significantly reduced when women regularly attend screening mammograms ...

Time November 30, 2023
arrow
News | Breast Imaging

November 29, 2023 — A deep learning artificial intelligence (AI) model that was developed using only mammogram image ...

Time November 29, 2023
arrow
News | RSNA

November 28, 2023 — iCAD, Inc., a global medical technology company developing cancer-detection solutions, will present ...

Time November 28, 2023
arrow
News | Artificial Intelligence

November 6, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is set to ...

Time November 06, 2023
arrow
Feature | Breast Imaging | By Laura Heacock, MS, MD

Breast cancer remains a significant health concern, responsible for more than 600,000 deaths annually. Early detection ...

Time November 03, 2023
arrow
Feature | ACR | By Christine Book

October 31, 2023 — As another Breast Cancer Awareness Month comes to a close, Imaging Technology News is sharing ...

Time October 31, 2023
arrow
News | Women's Health

October 6, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, and Leeds ...

Time October 06, 2023
arrow
Feature | Breast Imaging | By Susan Harvey, MD, FSBI

In countries with organized screening programs, regular breast cancer screening has been a crucial tool in the clinician ...

Time September 22, 2023
arrow
News | Artificial Intelligence

September 11, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is ...

Time September 11, 2023
arrow
News | Mammography

September 5, 2023 — Using a standardized assessment, researchers in the UK compared the performance of a commercially ...

Time September 05, 2023
arrow
Subscribe Now